Human anti-IL-6 antibodies with extended in vivo half-life and their use in treatment of oncology, autoimmune diseases and inflammatory diseases

Details for Australian Patent Application No. 2010208125 (hide)

Owner MedImmune, LLC

Inventors Bowen, Michael; Wu, Herren; Dall'Acqua, William; Kiener, Peter; Jallal, Bahija; Coyle, Anthony

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2010208125

PCT Pub. Number WO2010/088444

Priority 61/148,106 29.01.09 US; 61/184,182 04.06.09 US

Filing date 29 January 2010

Wipo publication date 5 August 2010

International Classifications

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

21 July 2011 PCT application entered the National Phase

  PCT publication WO2010/088444 Priority application(s): WO2010/088444

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010208133-Non-invasive methods and apparatus for detecting insect-induced damage in a plant

2010208123-Methods for pancreatic tissue regeneration